Jacob Orville serves as the Executive Vice President and General Manager, Screening at EXACT SCIENCES CORP, a leading provider of cancer screening and diagnostic tests. In his role, Orville is responsible for overseeing the company's flagship product, Cologuard, a non-invasive stool-based DNA test for colorectal cancer screening. He leads a team of professionals dedicated to expanding access to life-saving cancer screening and improving patient outcomes. Prior to joining Exact Sciences, Orville held various leadership positions in the healthcare and diagnostics industry. He spent over a decade at Abbott Laboratories, where he played a key role in the development and commercialization of innovative diagnostic solutions. Orville's strategic vision and ability to drive growth have been instrumental in his success. He holds a Master of Business Administration from the University of Chicago Booth School of Business and a Bachelor of Science in Biomedical Engineering from the University of Wisconsin-Madison. Under Orville's leadership, Exact Sciences has continued to expand its reach and impact in the field of cancer screening. He has been instrumental in driving the adoption of Cologuard and increasing awareness of the importance of early detection. Orville's commitment to improving patient care and his passion for innovation have made him a respected leader in the industry. As Exact Sciences continues to grow and develop new screening technologies, Orville's expertise and dedication will be crucial in shaping the company's future success.